Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Investigating how sleep reactivity affects shift work disorder

Official title: Sleep Reactivity as a Novel Mechanism in Shift Work Disorder

Run by Henry Ford Health System · NCT05424406 · Data updated 2026-11-12

This study is testing if how sensitive your sleep is can cause Shift Work Disorder and if treating sleep issues with therapy can help people who still have problems after adjusting their sleep schedule.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment150 (estimated)
SponsorHenry Ford Health System
Academic / other
Locations1 site (Novi, Michigan)
StatusRecruiting
StartedJanuary 1, 2023
Main results expectedJune 30, 2027
Study endsOctober 1, 2027
Registry record updatedOctober 16, 2026
Trial IDNCT05424406 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older who work fixed night shifts and have been diagnosed with Shift Work Disorder.

Probably not a fit

Patients with pre-existing insomnia disorders or other sleep disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project aims to test the role of sleep reactivity as an independent cause of Shift Work Disorder (SWD). It will involve a two-step mechanistic randomized controlled trial design with 150 participants who have SWD and varying levels of sleep reactivity. The first step will experimentally reduce circadian misalignment, while the second step will assess the impact of Cognitive Behavioral Therapy (CBT) on those who remain symptomatic. The study seeks to establish sleep reactivity as a predictor of insomnia and sleepiness in SWD, independent of circadian factors.

Why it matters

Potential benefit: If successful, this study could lead to improved treatment strategies for individuals suffering from Shift Work Disorder.

How similar studies have gone: Other studies have explored the effects of circadian misalignment and sleep reactivity, but this specific approach is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Participants must be working a fixed nightshift schedule, operationalized as: a) working at least three night shifts a week, b) shifts must begin between 18:00 and 02:00, and last between 8 to 12 hours, and c) must also plan to maintain the nightshift schedule for the duration of the study
* Participants must have Shift Work Disorder, which will be diagnosed based on ICSD-3 criteria
* Participants must show circadian misalignment, operationalized as a baseline melatonin onset between 18:00 and 01:00.
* Participants must be at least 18 years old

Exclusion Criteria:

* Insomnia disorder or excessive sleepiness predating the onset of shift work
* Termination of nightshift schedule
* Presence of other sleep disorders (e.g. obstructive sleep apnea, narcolepsy) determined by standard clinical polysomnography
* Diagnosis of bipolar disorder
* History of neurological disorders determined by self-report and medical history
* Pregnancy
* Alcohol use disorder
* Illicit drug use via self-report and urine drug screen if reasonable suspicion to test

Where it's running

  • Henry Ford Columbus Medical Center
    Novi, Michigan, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.